Welcome to NDPIA!
The National Doctoral Programme in Infection and Antibiotics (NDPIA) is a research school funded by The Swedish Research Council (VR) and is affiliated with MIMS (Laboratory for Molecular Infection Medicine Sweden, Umeå University) and the Swedish National Network for Infection Biology.
NDPIA has the goal to connect research environments studying infection biology and antibiotics throughout Sweden by offering courses & workshops, conferences, research stays in Sweden and abroad, and network meetings that promote scientific research and recruitment of young scientists.
NDPIA supports participation in these activities by co-funding of travel and accommodation costs. PhD students and postdoctoral fellows enrolled at a Swedish university/institute or with one of our international partners and studying infection biology and antibiotics are welcome to apply for membership here.
Recent news:
This course introduces participants to AI methods used to predict disease outbreaks, to predict antibiotic resistance of pathogens, to survey pathogens and antibiotic resistance in the environment, to decipher host-pathogen interactions, to aid the development of new antimicrobials and to use AI responsibly.
In addition, three workshops are given that focus on the AlphaFold AI system, SIAMCAT metagenomic data analysis and scientific automation.
Abstract submission deadline: 8 April 2024
Since there are spots left for the Antibiotics and Antibiotic Resistance course in April, we will keep registration open for a few more days!
View the preliminary course schedule and register here
Methicillin-resistant Staphylococcus aureus (MRSA). Courtesy: National Institute of Allergy and Infectious Diseases
This five-day intensive course for NDPIA members introduces antibiotic resistance from a microbial perspective and from a clinical – One Health perspective.
- the modes of action of different antibiotics and how microbes resist the effects of the antibiotics,
- diagnostic methods to detect known and novel resistance genes,
- the origins of resistance genes and the biological cost of resistance for the microbe, and
-
modern methodology for new antibiotic development and alternative therapeutics for infectious disease
Abstract submission deadline: 4 March, 2024